FDA APPROVES ANOTHER KENSEY NASH CATHETER SYSTEM

Kensey Nash Corp. said Thursday that the Food and Drug Administration has approved its ThromCat blood-clot-removal catheter system. The company plans a product launch within three months. Kensey Nash said the first use of the ThromCat system will be for AV grafts and fistulas. Philadelphia Business Journal (http://philadelphia.bizjournals.com/philadelphia/stories/2006/04/24/daily38.html?jst=b_ln_hl)